Get the Stockscreener App
1.61
5.29%
-0.09
Gri Bio Inc stock is traded at $1.61, with a volume of 79,366.
It is down -5.29% in the last 24 hours and down -15.71% over the past month.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
See More
Previous Close:
$1.70
Open:
$1.7
24h Volume:
79,366
Relative Volume:
0.07
Market Cap:
$4.05M
Revenue:
-
Net Income/Loss:
$-8.26M
P/E Ratio:
-0.03
EPS:
-53.609
Net Cash Flow:
$-12.17M
1W Performance:
-20.30%
1M Performance:
-15.71%
6M Performance:
-23.33%
1Y Performance:
-91.39%
1-Day Range:
$1.58
$1.70
1-Week Range:
$1.58
$2.04
52-Week Range:
$1.10
$21.08
Gri Bio Inc Stock (GRI) Company Profile
Name
Gri Bio Inc
Sector
Industry
Phone
(619) 400-1171
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA
Compare GRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
1.61 | 4.28M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.61 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.11 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | H.C. Wainwright | Buy |
Gri Bio Inc Stock (GRI) Latest News
GRI Bio Inc. stock daily chart insightsGold Moves & Low Drawdown Trading Strategies - newser.com
Using economic indicators to assess GRI Bio Inc. potentialEarnings Overview Summary & Free High Accuracy Swing Entry Alerts - newser.com
Visual analytics tools that track GRI Bio Inc. performanceMarket Trend Review & Step-by-Step Trade Execution Guides - newser.com
How GRI Bio Inc. stock performs in rate cut cyclesJuly 2025 Technicals & Fast Moving Trade Plans - newser.com
Is GRI Bio Inc. meeting your algorithmic filter criteriaQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Will GRI Bio Inc. stock see insider buyingJuly 2025 PostEarnings & Weekly Breakout Opportunity Watchlist - newser.com
What does recent volatility data suggest for GRI Bio Inc.Trade Analysis Report & Verified Swing Trading Watchlist - newser.com
Smart tools for monitoring GRI Bio Inc.’s price actionBuy Signal & Fast Moving Stock Watchlists - newser.com
Why GRI Bio Inc. stock is considered a top pickPortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Technical analysis overview for GRI Bio Inc. stock2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Backtesting results for GRI Bio Inc. trading strategiesPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
How supply chain issues affect GRI Bio Inc. stockOptions Play & Scalable Portfolio Growth Ideas - newser.com
Will GRI Bio Inc. stock outperform value stocksWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Analyzing net buyer seller activity in GRI Bio Inc.Weekly Profit Report & Verified Entry Point Detection - newser.com
Gri Bio Inc Stock (GRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):